Singapore: Non-Hodgkin Lymphoma (NHL) treatment market in Asia-Pacific (APAC) countries including India, Australia, Chin...
Singapore: Shanghai-based Hua Medicine announced the closing of a $25 million series B funding that will enable the comp...
Singapore: When we think "hybrid" we think of taking the best components from often opposing approaches and forming a ne...
Singapore: Concord Medical Services Holdings, a leading specialty hospital management solution provider and operator of...
China continues to dominate the pharmaceutical market in Asia, both as a producer of active pharmaceutical ingredients (...
Singapore: Colder products, a leading player in connecting solutions, has announced the launch of its combination produc...
Singapore: Israel-based D-Pharm has recieved new patent in the US and China, related to composition and use of THR-18, a...
Singapore: British investigators and owners of ChinaWhys, Mr Peter Humphrey and his American wife Ms Yu Yingzeng stood f...
Singapore: Lifetech's Ceraflex occluders would be the first Chinese medical devices brand to enter the western medical d...
Sigma-Aldrich, a leading life sciences and high technology company headquartered in the US, recently opened new faciliti...
Singapore: Tianyin Pharmaceutical, China based biopharmaceutical company, has received non-compliance notice from New Yo...
Singapore: Chinese biotechnology firm, 3SBio, has signed an exclusive license with Korean firm, DiNonA for the develop...
Singapore: China is all set to host Medical Device Innovative Technology Forum and Regulation Summit (MEDTEC China) on ...
Singapore: Medidata, global provider of cloud-based solutions for clinical research in life sciences, has expanded its p...
Singapore: Taiwan-based ScinoPharm and China-based Nanjing King-friend Biochemical Pharmaceutical have entered into a co...
Singapore: Ally Bridge Group (ABG), a global healthcare-focused investment platform, has expanded its global biopharmace...
Singapore: According to sources, a Chinese court has imposed a fine of $489 million on the British drug maker, Glaxosmit...
Singapore: After increasing probes into operations of pharmaceutical multinational operations in China, the country's St...
